CN Stock MarketDetailed Quotes

003020 Hefei Lifeon Pharmaceutical

Watchlist
  • 19.99
  • -0.20-0.99%
Market Closed Jun 14 15:00 CST
3.83BMarket Cap20.05P/E (TTM)

Hefei Lifeon Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-36.62%187.75M
-21.73%502.93M
-37.38%202.71M
-13.19%236.54M
64.49%296.24M
-1.78%642.58M
31.89%323.72M
56.30%272.48M
6.24%180.1M
-14.65%654.25M
Transactional financial assets
3.99%322.49M
53,216.45%61.52M
-21.84%266.48M
-18.90%326.49M
-29.54%310.11M
-12.95%115.39K
-15.03%340.96M
-15.48%402.56M
-19.98%440.12M
--132.55K
Notes receivable and accounts receivable
-39.37%282.39M
-19.25%259.24M
-48.66%236.56M
-48.54%189.43M
3.42%465.77M
0.90%321.02M
8.46%460.81M
8.73%368.13M
21.69%450.37M
17.86%318.17M
-Notes receivable
--200K
700.00%792K
--807.5K
----
----
-99.72%99K
----
--0
-9.29%34.93M
1.76%35.51M
-Accounts receivable
-39.41%282.19M
-19.47%258.45M
-48.84%235.75M
-48.54%189.43M
12.12%465.77M
13.54%320.92M
18.07%460.81M
16.64%368.13M
25.28%415.43M
20.25%282.66M
Other receivables (including interest and dividends)
111.68%20.72M
361.29%19.97M
695.97%40.73M
1,127.34%74.04M
25.57%9.79M
-28.80%4.33M
18.08%5.12M
75.86%6.03M
73.17%7.8M
97.92%6.08M
-Dividend receivable
--4.96M
--4.96M
--34.96M
--69.31M
----
----
----
----
----
----
-Accrued interest receivable
----
----
----
--0
----
----
----
----
----
----
-Other receivable
----
----
----
-21.62%4.73M
----
-28.80%4.33M
----
75.86%6.03M
----
97.92%6.08M
Advance payment
-13.38%43.07M
-88.46%9.36M
-47.55%24.23M
-74.07%18.28M
5.48%49.72M
57.55%81.07M
-14.65%46.21M
103.23%70.51M
7.31%47.14M
30.54%51.46M
Inventories
-38.04%231.14M
-32.85%242.91M
-19.50%258.72M
-34.75%172.74M
36.33%373.04M
91.55%361.76M
47.45%321.4M
20.68%264.73M
26.55%273.63M
-2.55%188.86M
Receivable financing
-22.18%30.41M
13.39%35.95M
-20.46%26.38M
7.91%39.57M
57.21%39.08M
15,851.35%31.7M
478.88%33.17M
2,205.22%36.67M
208.59%24.86M
-98.70%198.75K
Other current assets
64.65%21.89M
93.43%19.26M
274.46%17.55M
933.77%15.63M
1,009.05%13.29M
1,913.84%9.96M
470.68%4.69M
-16.38%1.51M
-43.84%1.2M
-73.82%494.56K
Total current assets
-26.79%1.14B
-20.75%1.15B
-30.12%1.07B
-24.60%1.07B
9.25%1.56B
19.10%1.45B
13.40%1.54B
13.80%1.42B
4.45%1.43B
-5.46%1.22B
Non Current assets
Other equity investment
--16.44M
--16.44M
--1.44M
----
----
--0
----
----
----
----
Investment real estate
5.71%25.42M
858.94%25.62M
1,087.85%32.98M
888.13%28.47M
705.29%24.05M
-13.58%2.67M
-13.13%2.78M
-12.72%2.88M
-12.33%2.99M
-11.96%3.09M
Long-term equity investment
287.79%169.6M
1,038.71%163.95M
939.46%157.05M
743.12%157.75M
126.99%43.74M
-30.47%14.4M
-15.46%15.11M
-1.84%18.71M
-3.13%19.27M
--20.71M
Fixed assets
----
----
----
-10.18%152.8M
----
28.54%182.38M
----
16.51%170.12M
----
7.03%141.89M
Constru in process
----
----
----
112.62%425.59M
----
161.52%340.89M
----
158.88%200.17M
----
96.12%130.35M
Productive biological assets
--2.41M
--2.4M
--2.4M
----
----
----
----
----
----
----
Intangible assets
34.57%110.96M
35.86%113.29M
20.22%101.63M
-11.49%76.01M
-6.26%82.45M
-6.84%83.38M
-6.69%84.54M
121.15%85.88M
127.18%87.96M
184.87%89.51M
Development expenditure
173.39%2.82M
50.39%2.08M
94.99%2.15M
90.38%1.4M
40.46%1.03M
88.42%1.39M
164.08%1.1M
--735.6K
--735.6K
--735.6K
Goodwill
--74.44M
--74.44M
--73.53M
----
----
----
----
----
----
----
Long deferred expense
-0.02%5.71M
-14.51%5.32M
-17.15%5.46M
-26.91%5.21M
-24.13%5.71M
-22.72%6.23M
-17.63%6.6M
-12.80%7.13M
852.43%7.53M
797.52%8.06M
Deferred tax assets
45.16%15.73M
88.00%16.13M
64.93%12.32M
82.78%12.94M
79.14%10.84M
46.42%8.58M
80.40%7.47M
49.79%7.08M
57.69%6.05M
73.74%5.86M
Usufruct assets
-38.17%8.1M
-37.37%9.3M
-47.57%10.56M
-48.87%11M
-47.17%13.09M
-44.58%14.85M
-36.66%20.13M
-34.09%21.52M
30.94%24.78M
26.27%26.79M
Other non current assets
85.93%21.98M
18.14%16.64M
-28.08%16.78M
-39.02%15.46M
-74.14%11.82M
-49.34%14.09M
-17.15%23.33M
-24.53%25.36M
471.05%45.71M
377.51%27.81M
Total non current assets
80.85%1.35B
99.23%1.33B
94.10%1.14B
64.32%886.64M
57.76%748.98M
47.07%668.85M
41.78%589.27M
48.36%539.59M
60.94%474.76M
71.44%454.8M
Total assets
8.17%2.49B
17.08%2.48B
4.32%2.22B
-0.15%1.96B
21.37%2.31B
26.69%2.12B
20.06%2.13B
21.59%1.96B
14.49%1.9B
7.66%1.67B
Liabilities
Current liabilities
Short term loan
----
----
----
----
--41.99M
----
----
----
----
----
Notes payable and accounts payable
-43.57%308.24M
-34.60%301.25M
-45.57%290.07M
-51.76%234.8M
23.93%546.25M
89.63%460.66M
30.73%532.94M
61.62%486.77M
23.20%440.78M
-13.33%242.93M
-Notes payable
----
----
----
----
5.31%194.01M
128.15%213.72M
55.78%183.62M
82.62%235.1M
25.74%184.22M
-42.12%93.68M
-Accounts payable
-12.49%308.24M
22.00%301.25M
-16.96%290.07M
-6.70%234.8M
37.29%352.24M
65.45%246.94M
20.55%349.33M
45.95%251.67M
21.43%256.56M
26.02%149.25M
Contract liabilities
-22.30%16.35M
-74.87%10.71M
26.82%19.25M
2.57%17.67M
23.78%21.04M
190.08%42.62M
31.83%15.18M
47.84%17.23M
-4.00%17M
-26.59%14.69M
Advance receipts
----
--276.4K
----
--258.93K
----
----
----
----
----
----
Salaries payable
12.71%18.83M
23.19%32.38M
10.96%24.52M
34.09%21.57M
19.44%16.71M
5.50%26.28M
22.79%22.09M
14.15%16.09M
21.15%13.99M
19.29%24.91M
Taxs payable
-30.76%28M
29.82%35.94M
-25.13%20.74M
60.22%29.86M
106.28%40.43M
-6.63%27.68M
78.54%27.7M
61.69%18.64M
128.15%19.6M
257.18%29.65M
Other payable (including interest and dividends)
154.34%142.02M
214.26%156.41M
49.46%74.12M
192.63%64.2M
260.50%55.84M
252.92%49.77M
233.76%49.59M
61.91%21.94M
58.86%15.49M
32.56%14.1M
-Dividend payable
--15.68M
--15.68M
----
----
----
----
----
----
----
----
-Other payable
----
----
----
192.63%64.2M
----
252.92%49.77M
----
61.91%21.94M
----
32.56%14.1M
Non current liabilities due within one year
-48.52%4.93M
-54.77%4.54M
--5.36M
-34.80%4.94M
--9.59M
--10.03M
----
--7.58M
----
----
Other current liabilities
-53.38%1.99M
-78.00%1.23M
49.70%2.8M
5.36%2.23M
102.13%4.28M
215.66%5.59M
36.72%1.87M
47.90%2.12M
-6.01%2.12M
-20.73%1.77M
Total current liabilities
-29.31%520.37M
-12.83%542.73M
-32.73%436.86M
-34.16%375.54M
44.63%736.12M
89.79%622.63M
38.49%649.38M
61.38%570.36M
24.86%508.97M
-4.18%328.05M
Current liabilities
Long term loan
--31M
--31.01M
----
----
----
----
----
----
----
----
Long term account payable
----
----
----
--0
----
--0
----
--0
----
--0
Specific account payable
----
----
----
-96.13%1.16M
----
-75.11%1.16M
----
310.40%29.96M
----
-36.17%4.66M
Deferred tax liabilities
824.34%13.14M
868.11%13.43M
8,236.25%11.06M
985.30%4.28M
788.81%1.42M
--1.39M
-14.65%132.62K
101.78%394.37K
--159.9K
----
Long term deferred income
57.56%19.67M
55.35%20.16M
4.39%14.07M
-1.37%11.98M
-2.32%12.48M
-1.95%12.98M
20.75%13.48M
4.80%12.15M
6.25%12.78M
6.94%13.24M
Lease liabilities
-32.68%1.38M
-15.91%2.84M
-82.95%3.16M
-62.90%4.5M
-90.85%2.05M
-86.25%3.38M
-37.53%18.52M
-59.61%12.12M
32.91%22.36M
27.32%24.58M
Total non current liabilities
280.97%65.18M
256.77%67.45M
-52.58%29.44M
-59.87%21.92M
-57.18%17.11M
-55.49%18.91M
28.64%62.09M
11.25%54.62M
10.54%39.96M
8.96%42.48M
Total liabilities
-22.26%585.55M
-4.89%610.18M
-34.46%466.3M
-36.40%397.46M
37.22%753.23M
73.14%641.53M
37.57%711.47M
55.26%624.99M
23.70%548.93M
-2.83%370.53M
Shareholders equity
Paid-in capital
30.36%159.64M
30.38%159.68M
30.38%159.68M
32.20%159.21M
32.20%122.47M
32.20%122.47M
32.20%122.47M
30.00%120.43M
0.00%92.64M
0.00%92.64M
Capital reserve funds
-1.07%555.36M
-0.55%551.89M
2.41%540.36M
6.34%529.96M
6.69%561.36M
5.47%554.93M
1.05%527.64M
-4.55%498.37M
0.77%526.16M
0.77%526.16M
Surplus reserve funds
29.36%81.98M
29.36%81.98M
35.18%65.51M
32.55%64.23M
30.77%63.37M
30.77%63.37M
0.76%48.46M
0.76%48.46M
0.76%48.46M
0.76%48.46M
Retained profit
12.73%938.61M
19.17%912.97M
17.31%870.86M
24.71%835.53M
21.77%832.63M
20.34%766.13M
25.79%742.35M
22.17%669.97M
23.69%683.77M
24.56%636.65M
Less:Treasury stock
-23.62%20.66M
-22.41%20.99M
17.03%31.65M
--27.05M
--27.05M
--27.05M
--27.05M
----
----
--0
Shareholders equity without minority interests
10.44%1.71B
13.90%1.69B
13.50%1.6B
16.80%1.56B
14.93%1.55B
13.49%1.48B
12.84%1.41B
10.40%1.34B
11.13%1.35B
11.07%1.3B
Minority interests
--193.9M
--187.97M
--146.1M
----
----
----
----
----
----
----
Total shareholder equity
22.93%1.91B
26.60%1.87B
23.83%1.75B
16.80%1.56B
14.93%1.55B
13.49%1.48B
12.84%1.41B
10.40%1.34B
11.13%1.35B
11.07%1.3B
Total liabilityies and equity
8.17%2.49B
17.08%2.48B
4.32%2.22B
-0.15%1.96B
21.37%2.31B
26.69%2.12B
20.06%2.13B
21.59%1.96B
14.49%1.9B
7.66%1.67B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -36.62%187.75M-21.73%502.93M-37.38%202.71M-13.19%236.54M64.49%296.24M-1.78%642.58M31.89%323.72M56.30%272.48M6.24%180.1M-14.65%654.25M
Transactional financial assets 3.99%322.49M53,216.45%61.52M-21.84%266.48M-18.90%326.49M-29.54%310.11M-12.95%115.39K-15.03%340.96M-15.48%402.56M-19.98%440.12M--132.55K
Notes receivable and accounts receivable -39.37%282.39M-19.25%259.24M-48.66%236.56M-48.54%189.43M3.42%465.77M0.90%321.02M8.46%460.81M8.73%368.13M21.69%450.37M17.86%318.17M
-Notes receivable --200K700.00%792K--807.5K---------99.72%99K------0-9.29%34.93M1.76%35.51M
-Accounts receivable -39.41%282.19M-19.47%258.45M-48.84%235.75M-48.54%189.43M12.12%465.77M13.54%320.92M18.07%460.81M16.64%368.13M25.28%415.43M20.25%282.66M
Other receivables (including interest and dividends) 111.68%20.72M361.29%19.97M695.97%40.73M1,127.34%74.04M25.57%9.79M-28.80%4.33M18.08%5.12M75.86%6.03M73.17%7.8M97.92%6.08M
-Dividend receivable --4.96M--4.96M--34.96M--69.31M------------------------
-Accrued interest receivable --------------0------------------------
-Other receivable -------------21.62%4.73M-----28.80%4.33M----75.86%6.03M----97.92%6.08M
Advance payment -13.38%43.07M-88.46%9.36M-47.55%24.23M-74.07%18.28M5.48%49.72M57.55%81.07M-14.65%46.21M103.23%70.51M7.31%47.14M30.54%51.46M
Inventories -38.04%231.14M-32.85%242.91M-19.50%258.72M-34.75%172.74M36.33%373.04M91.55%361.76M47.45%321.4M20.68%264.73M26.55%273.63M-2.55%188.86M
Receivable financing -22.18%30.41M13.39%35.95M-20.46%26.38M7.91%39.57M57.21%39.08M15,851.35%31.7M478.88%33.17M2,205.22%36.67M208.59%24.86M-98.70%198.75K
Other current assets 64.65%21.89M93.43%19.26M274.46%17.55M933.77%15.63M1,009.05%13.29M1,913.84%9.96M470.68%4.69M-16.38%1.51M-43.84%1.2M-73.82%494.56K
Total current assets -26.79%1.14B-20.75%1.15B-30.12%1.07B-24.60%1.07B9.25%1.56B19.10%1.45B13.40%1.54B13.80%1.42B4.45%1.43B-5.46%1.22B
Non Current assets
Other equity investment --16.44M--16.44M--1.44M----------0----------------
Investment real estate 5.71%25.42M858.94%25.62M1,087.85%32.98M888.13%28.47M705.29%24.05M-13.58%2.67M-13.13%2.78M-12.72%2.88M-12.33%2.99M-11.96%3.09M
Long-term equity investment 287.79%169.6M1,038.71%163.95M939.46%157.05M743.12%157.75M126.99%43.74M-30.47%14.4M-15.46%15.11M-1.84%18.71M-3.13%19.27M--20.71M
Fixed assets -------------10.18%152.8M----28.54%182.38M----16.51%170.12M----7.03%141.89M
Constru in process ------------112.62%425.59M----161.52%340.89M----158.88%200.17M----96.12%130.35M
Productive biological assets --2.41M--2.4M--2.4M----------------------------
Intangible assets 34.57%110.96M35.86%113.29M20.22%101.63M-11.49%76.01M-6.26%82.45M-6.84%83.38M-6.69%84.54M121.15%85.88M127.18%87.96M184.87%89.51M
Development expenditure 173.39%2.82M50.39%2.08M94.99%2.15M90.38%1.4M40.46%1.03M88.42%1.39M164.08%1.1M--735.6K--735.6K--735.6K
Goodwill --74.44M--74.44M--73.53M----------------------------
Long deferred expense -0.02%5.71M-14.51%5.32M-17.15%5.46M-26.91%5.21M-24.13%5.71M-22.72%6.23M-17.63%6.6M-12.80%7.13M852.43%7.53M797.52%8.06M
Deferred tax assets 45.16%15.73M88.00%16.13M64.93%12.32M82.78%12.94M79.14%10.84M46.42%8.58M80.40%7.47M49.79%7.08M57.69%6.05M73.74%5.86M
Usufruct assets -38.17%8.1M-37.37%9.3M-47.57%10.56M-48.87%11M-47.17%13.09M-44.58%14.85M-36.66%20.13M-34.09%21.52M30.94%24.78M26.27%26.79M
Other non current assets 85.93%21.98M18.14%16.64M-28.08%16.78M-39.02%15.46M-74.14%11.82M-49.34%14.09M-17.15%23.33M-24.53%25.36M471.05%45.71M377.51%27.81M
Total non current assets 80.85%1.35B99.23%1.33B94.10%1.14B64.32%886.64M57.76%748.98M47.07%668.85M41.78%589.27M48.36%539.59M60.94%474.76M71.44%454.8M
Total assets 8.17%2.49B17.08%2.48B4.32%2.22B-0.15%1.96B21.37%2.31B26.69%2.12B20.06%2.13B21.59%1.96B14.49%1.9B7.66%1.67B
Liabilities
Current liabilities
Short term loan ------------------41.99M--------------------
Notes payable and accounts payable -43.57%308.24M-34.60%301.25M-45.57%290.07M-51.76%234.8M23.93%546.25M89.63%460.66M30.73%532.94M61.62%486.77M23.20%440.78M-13.33%242.93M
-Notes payable ----------------5.31%194.01M128.15%213.72M55.78%183.62M82.62%235.1M25.74%184.22M-42.12%93.68M
-Accounts payable -12.49%308.24M22.00%301.25M-16.96%290.07M-6.70%234.8M37.29%352.24M65.45%246.94M20.55%349.33M45.95%251.67M21.43%256.56M26.02%149.25M
Contract liabilities -22.30%16.35M-74.87%10.71M26.82%19.25M2.57%17.67M23.78%21.04M190.08%42.62M31.83%15.18M47.84%17.23M-4.00%17M-26.59%14.69M
Advance receipts ------276.4K------258.93K------------------------
Salaries payable 12.71%18.83M23.19%32.38M10.96%24.52M34.09%21.57M19.44%16.71M5.50%26.28M22.79%22.09M14.15%16.09M21.15%13.99M19.29%24.91M
Taxs payable -30.76%28M29.82%35.94M-25.13%20.74M60.22%29.86M106.28%40.43M-6.63%27.68M78.54%27.7M61.69%18.64M128.15%19.6M257.18%29.65M
Other payable (including interest and dividends) 154.34%142.02M214.26%156.41M49.46%74.12M192.63%64.2M260.50%55.84M252.92%49.77M233.76%49.59M61.91%21.94M58.86%15.49M32.56%14.1M
-Dividend payable --15.68M--15.68M--------------------------------
-Other payable ------------192.63%64.2M----252.92%49.77M----61.91%21.94M----32.56%14.1M
Non current liabilities due within one year -48.52%4.93M-54.77%4.54M--5.36M-34.80%4.94M--9.59M--10.03M------7.58M--------
Other current liabilities -53.38%1.99M-78.00%1.23M49.70%2.8M5.36%2.23M102.13%4.28M215.66%5.59M36.72%1.87M47.90%2.12M-6.01%2.12M-20.73%1.77M
Total current liabilities -29.31%520.37M-12.83%542.73M-32.73%436.86M-34.16%375.54M44.63%736.12M89.79%622.63M38.49%649.38M61.38%570.36M24.86%508.97M-4.18%328.05M
Current liabilities
Long term loan --31M--31.01M--------------------------------
Long term account payable --------------0------0------0------0
Specific account payable -------------96.13%1.16M-----75.11%1.16M----310.40%29.96M-----36.17%4.66M
Deferred tax liabilities 824.34%13.14M868.11%13.43M8,236.25%11.06M985.30%4.28M788.81%1.42M--1.39M-14.65%132.62K101.78%394.37K--159.9K----
Long term deferred income 57.56%19.67M55.35%20.16M4.39%14.07M-1.37%11.98M-2.32%12.48M-1.95%12.98M20.75%13.48M4.80%12.15M6.25%12.78M6.94%13.24M
Lease liabilities -32.68%1.38M-15.91%2.84M-82.95%3.16M-62.90%4.5M-90.85%2.05M-86.25%3.38M-37.53%18.52M-59.61%12.12M32.91%22.36M27.32%24.58M
Total non current liabilities 280.97%65.18M256.77%67.45M-52.58%29.44M-59.87%21.92M-57.18%17.11M-55.49%18.91M28.64%62.09M11.25%54.62M10.54%39.96M8.96%42.48M
Total liabilities -22.26%585.55M-4.89%610.18M-34.46%466.3M-36.40%397.46M37.22%753.23M73.14%641.53M37.57%711.47M55.26%624.99M23.70%548.93M-2.83%370.53M
Shareholders equity
Paid-in capital 30.36%159.64M30.38%159.68M30.38%159.68M32.20%159.21M32.20%122.47M32.20%122.47M32.20%122.47M30.00%120.43M0.00%92.64M0.00%92.64M
Capital reserve funds -1.07%555.36M-0.55%551.89M2.41%540.36M6.34%529.96M6.69%561.36M5.47%554.93M1.05%527.64M-4.55%498.37M0.77%526.16M0.77%526.16M
Surplus reserve funds 29.36%81.98M29.36%81.98M35.18%65.51M32.55%64.23M30.77%63.37M30.77%63.37M0.76%48.46M0.76%48.46M0.76%48.46M0.76%48.46M
Retained profit 12.73%938.61M19.17%912.97M17.31%870.86M24.71%835.53M21.77%832.63M20.34%766.13M25.79%742.35M22.17%669.97M23.69%683.77M24.56%636.65M
Less:Treasury stock -23.62%20.66M-22.41%20.99M17.03%31.65M--27.05M--27.05M--27.05M--27.05M----------0
Shareholders equity without minority interests 10.44%1.71B13.90%1.69B13.50%1.6B16.80%1.56B14.93%1.55B13.49%1.48B12.84%1.41B10.40%1.34B11.13%1.35B11.07%1.3B
Minority interests --193.9M--187.97M--146.1M----------------------------
Total shareholder equity 22.93%1.91B26.60%1.87B23.83%1.75B16.80%1.56B14.93%1.55B13.49%1.48B12.84%1.41B10.40%1.34B11.13%1.35B11.07%1.3B
Total liabilityies and equity 8.17%2.49B17.08%2.48B4.32%2.22B-0.15%1.96B21.37%2.31B26.69%2.12B20.06%2.13B21.59%1.96B14.49%1.9B7.66%1.67B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg